Suc-Leu-Leu-Val-Tyr-AMC
CAS: 94367-21-2
Ref. 3D-FS110535
2mg | 202,00 € | ||
5mg | 327,00 € | ||
10mg | 480,00 € | ||
50mg | 986,00 € | ||
100mg | 1.392,00 € |
Informação sobre produto
- Chymotrypsin Substrate III
- Fluorogenic
- N-succinyl-leu-leu-val-tyr 7-amido-4-*methylcouma
- Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide
- Llvy-mca
- N-Succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin
- Sllvt-mca
- Suc-leu-leu-val-tyr-7-amino-4-methylcoumarin
- Suc-leu-leu-val-tyr-mca
- Suc-llvy-mca
- Ver mais sinónimos
- L-Tyrosinamide, N-(3-carboxy-1-oxopropyl)-L-leucyl-L-leucyl-L-valyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
- N-(3-carboxypropanoyl)leucylleucyl-L-valyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-tyrosinamide
Suc-Leu-Leu-Val-Tyr-AMC is a cyclin D2 inhibitor that binds to the proteasome and inhibits its function. It has been shown to be useful for the treatment of cancerous tissues as it inhibits the production of prostaglandin J2, which is involved in the progression of cancer cells. Suc-Leu-Leu-Val-Tyr-AMC has also been shown to have antioxidant properties and can inhibit oxidative injury. This drug may be used to prevent or treat various diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, diabetes mellitus type II, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and septic shock.
Propriedades químicas
Consulta técnica sobre: 3D-FS110535 Suc-Leu-Leu-Val-Tyr-AMC
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.